Profil
Jean Combalbert is the founder of Epics Therapeutics SA, serving as Director since 2018.
Current job includes Chairman at Syndesi Therapeutics SA. Former jobs include Chairman & Chief Executive Officer at Entomed SA from 2003 to 2009, Chief Executive Officer & Director at Ogeda SA, Non-Executive Chairman at Bioxodes SA, Director at Pharnext SA from 2020 to 2021, and Principal at Sanofi.
Education includes a doctorate from the University of Marseille.
Aktive Positionen von Jean Combalbert
| Unternehmen | Position | Beginn |
|---|---|---|
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Gründer | 20.02.2018 |
Syndesi Therapeutics SA
Syndesi Therapeutics SA BiotechnologyHealth Technology Develops treatments for CNS disorders | Vorsitzender | - |
Ehemalige bekannte Positionen von Jean Combalbert
| Unternehmen | Position | Ende |
|---|---|---|
| PHARNEXT SCA | Direktor/Vorstandsmitglied | 15.07.2021 |
Entomed SA
Entomed SA Pharmaceuticals: MajorHealth Technology Discovers and develops anti-infective drugs derived from insects | Vorsitzender | 03.02.2009 |
Bioxodes SA
Bioxodes SA BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapeutics targeting thrombo-inflammation | Vorsitzender | - |
| SANOFI | Corporate Officer/Principal | - |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Vorstandsvorsitzender | - |
Ausbildung von Jean Combalbert
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Entomed SA
Entomed SA Pharmaceuticals: MajorHealth Technology Discovers and develops anti-infective drugs derived from insects | Health Technology |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
University of Marseille
University of Marseille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharnext SA
Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases | Health Technology |
Bioxodes SA
Bioxodes SA BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapeutics targeting thrombo-inflammation | Health Technology |
Syndesi Therapeutics SA
Syndesi Therapeutics SA BiotechnologyHealth Technology Develops treatments for CNS disorders | Health Technology |
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
















